Quiescent Stem Cell Marker Genes in Glioma Gene Networks Are Sufficient to Distinguish Between Normal and Glioblastoma (GBM) Samples

Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples

Grade 4 glioma or GBM has poor prognosis and is the most aggressive grade of glioma. Accurate diagnosis and classification of tumor grade is a critical determinant for development of treatment pathway. Extensive genomic sequencing of gliomas, different cell types, brain tissue regions and advances in bioinformatics algorithms, have presented an opportunity to identify molecular markers that can complement existing histology and imaging methods u…

Hormel Institute scientists make discovery that could help fight aggressive child cancer

Scientists at The Hormel Institute, University of Minnesota, have made a groundbreaking discovery that could lead to new treatments for diffuse midline glioma.